Da-Min Xu1, Min Chen1, Fu-de Zhou2, Ming-Hui Zhao1. 1. Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Beijing, China; Key Laboratory of Renal Disease, National Health and Family Planning Commission of the People׳s Republic of China, Beijing, PR China. 2. Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Beijing, China; Key Laboratory of Renal Disease, National Health and Family Planning Commission of the People׳s Republic of China, Beijing, PR China. Electronic address: zhoufude1801@vip.sina.com.
Abstract
BACKGROUND: Percutaneous renal biopsy is essential for diagnosis of many renal diseases. Previous studies have revealed a variety of factors associated with bleeding complications of renal biopsy; however, data are not sufficient in the Chinese population. We aimed to investigate the risk factors for severe post-biopsy bleeding events in a large cohort of Chinese patients. MATERIALS AND METHODS: The data of patients who underwent percutaneous renal biopsy from January 2008 to December 2012 were collected. Severe bleeding complication was defined as requiring intervention, including blood transfusion or an invasive procedure (radiological or surgical) due to bleeding. Logistic regression analysis was used to assess risk factors. RESULTS: Over the 5-year period, 3,577 native kidney biopsies were performed. Severe bleeding complication occurred in 14 biopsies (0.39%). The patients with complications were older, had higher blood pressure, lower hemoglobin, lower platelet count and worse renal function. Multivariable logistic regression demonstrated that platelet level and the estimated glomerular filtration rate were independently associated with the risk of complications. Each 10 × 109/L increase of platelet count was associated with an 11% decrease of severe bleeding risk (odds ratio = 0.89; 95% CI: 0.80-0.98; P = 0.02). Each 1mL/minute/1.73m2 increase of the estimated glomerular filtration rate was associated with a 4% decrease of severe bleeding risk (odds ratio = 0.96; 95% CI: 0.94-0.99; P = 0.004). CONCLUSIONS: Patients with worse renal function and lower platelet counts had a higher risk of developing severe bleeding events after renal biopsy.
BACKGROUND: Percutaneous renal biopsy is essential for diagnosis of many renal diseases. Previous studies have revealed a variety of factors associated with bleeding complications of renal biopsy; however, data are not sufficient in the Chinese population. We aimed to investigate the risk factors for severe post-biopsy bleeding events in a large cohort of Chinese patients. MATERIALS AND METHODS: The data of patients who underwent percutaneous renal biopsy from January 2008 to December 2012 were collected. Severe bleeding complication was defined as requiring intervention, including blood transfusion or an invasive procedure (radiological or surgical) due to bleeding. Logistic regression analysis was used to assess risk factors. RESULTS: Over the 5-year period, 3,577 native kidney biopsies were performed. Severe bleeding complication occurred in 14 biopsies (0.39%). The patients with complications were older, had higher blood pressure, lower hemoglobin, lower platelet count and worse renal function. Multivariable logistic regression demonstrated that platelet level and the estimated glomerular filtration rate were independently associated with the risk of complications. Each 10 × 109/L increase of platelet count was associated with an 11% decrease of severe bleeding risk (odds ratio = 0.89; 95% CI: 0.80-0.98; P = 0.02). Each 1mL/minute/1.73m2 increase of the estimated glomerular filtration rate was associated with a 4% decrease of severe bleeding risk (odds ratio = 0.96; 95% CI: 0.94-0.99; P = 0.004). CONCLUSIONS:Patients with worse renal function and lower platelet counts had a higher risk of developing severe bleeding events after renal biopsy.
Authors: Kenaz Bakdash; Kristofer M Schramm; Aparna Annam; Matthew Brown; Kimi Kondo; Jonathan D Lindquist Journal: Semin Intervent Radiol Date: 2019-05-22 Impact factor: 1.513
Authors: Aksharaa Anpalahan; Eva Malacova; Katharine Hegerty; Andrew Malett; Dwarakanathan Ranganathan; Helen G Healy; Pedro Henrique Franca Gois Journal: Kidney360 Date: 2021-06-16
Authors: Shepherd Kajawo; Mothusi Walter Moloi; Jean Jacques Noubiap; Udeme Ekrikpo; Andre Pascal Kengne; Ikechi G Okpechi Journal: BMJ Open Date: 2018-04-27 Impact factor: 2.692
Authors: Frank E H P van Baarle; Emma K van de Weerdt; Bram Suurmond; Marcella C A Müller; Alexander P J Vlaar; Bart J Biemond Journal: Transfusion Date: 2020-01-31 Impact factor: 3.157